| Autor: |
Lima MC; Oswaldo Cruz Foundation/Fiocruz, Institute Aggeu Magalhães, Recife, Brazil., de Mendonça LR; Oswaldo Cruz Foundation/Fiocruz, Institute Aggeu Magalhães, Recife, Brazil., Rezende AM; Oswaldo Cruz Foundation/Fiocruz, Institute Aggeu Magalhães, Recife, Brazil., Carrera RM; Institute of Infection and Global Health, University of Liverpool, Liverpool, United Kingdom., Aníbal-Silva CE; Oswaldo Cruz Foundation/Fiocruz, Institute Aggeu Magalhães, Recife, Brazil., Demers M; Department of Psychiatry, University of Pittsburgh School of Medicine, Pittsburgh, PA, United States., D'Aiuto L; Department of Psychiatry, University of Pittsburgh School of Medicine, Pittsburgh, PA, United States., Wood J; Department of Psychiatry, University of Pittsburgh School of Medicine, Pittsburgh, PA, United States., Chowdari KV; Department of Psychiatry, University of Pittsburgh School of Medicine, Pittsburgh, PA, United States., Griffiths M; Institute of Infection and Global Health, University of Liverpool, Liverpool, United Kingdom., Lucena-Araujo AR; Federal University of Pernambuco/UFPE, Recife, Brazil., Barral-Netto M; Oswaldo Cruz Foundation/Fiocruz, Institute Gonçalo Moniz, Salvador, Brazil., Azevedo EAN; Oswaldo Cruz Foundation/Fiocruz, Institute Aggeu Magalhães, Recife, Brazil., Alves RW; Oswaldo Cruz Foundation/Fiocruz, Institute Aggeu Magalhães, Recife, Brazil., Farias PCS; Oswaldo Cruz Foundation/Fiocruz, Institute Aggeu Magalhães, Recife, Brazil., Marques ETA; Oswaldo Cruz Foundation/Fiocruz, Institute Aggeu Magalhães, Recife, Brazil.; Center for Vaccine Research, University of Pittsburgh, Pittsburgh, PA, United States., Castanha PMS; Center for Vaccine Research, University of Pittsburgh, Pittsburgh, PA, United States., Donald CL; MRC-University of Glasgow Centre for Virus Research, Glasgow, United Kingdom., Kohl A; MRC-University of Glasgow Centre for Virus Research, Glasgow, United Kingdom., Nimgaonkar VL; Department of Psychiatry, University of Pittsburgh School of Medicine, Pittsburgh, PA, United States.; Department of Human Genetics, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA, United States., Franca RFO; Oswaldo Cruz Foundation/Fiocruz, Institute Aggeu Magalhães, Recife, Brazil. |
| Abstrakt: |
Zika virus (ZIKV) infection during pregnancy is associated with microcephaly, a congenital malformation resulting from neuroinflammation and direct effects of virus replication on the developing central nervous system (CNS). However, the exact changes in the affected CNS remain unknown. Here, we show by transcriptome analysis (at 48 h post-infection) and multiplex immune profiling that human induced-neuroprogenitor stem cells (hiNPCs) respond to ZIKV infection with a strong induction of type-I interferons (IFNs) and several type-I IFNs stimulated genes (ISGs), notably cytokines and the pro-apoptotic chemokines CXCL9 and CXCL10. By comparing the inflammatory profile induced by a ZIKV Brazilian strain with an ancestral strain isolated from Cambodia in 2010, we observed that the response magnitude differs among them. Compared to ZIKV/Cambodia, the experimental infection of hiNPCs with ZIKV/Brazil resulted in a diminished induction of ISGs and lower induction of several cytokines (IFN-α, IL-1α/β, IL-6, IL-8, and IL-15), consequently favoring virus replication. From ZIKV-confirmed infant microcephaly cases, we detected a similar profile characterized by the presence of IFN-α, CXCL10, and CXCL9 in cerebrospinal fluid (CSF) samples collected after birth, evidencing a sustained CNS inflammation. Altogether, our data suggest that the CNS may be directly affected due to an unbalanced and chronic local inflammatory response, elicited by ZIKV infection, which contributes to damage to the fetal brain. |
